01.06.2026 • Product

ESILIB: FLTMC Finalist

ESILIB is one of the finalists for the From Lab to Market Challenge.

Public Voting

Vote now on your favourite start-up in the From Lab to Market Challenge!

Vote Here
Co-Founders
Christian Teske, Prachiti Ravindra Bedadur, Dr. Lukas Alexander Dold, and Chinmay Rajeev Bapat, Co-Founders, ESILIB
© ESILIB

We spoke with Co-Founders Lukas Alexander Dold (CEO), Christian Teske (CTO), Prachiti Ravindra Bedadur (COO), and Chinmay Rajeev Bapat (CCO) about ESILIB (Enhanced Silicon-Carbon-Composites for Lithium-Ion Batteries), one of the finalists in the From Lab to Market Challenge. 

CHEManager: What is your technology, and what makes it work?

Lukas Alexander Dold, Christian Teske, Prachiti Ravindra Bedadur, & Chinmay Rajeev BapatESILIB develops a novel silicon-carbon composite (Si/C) anode for Lithium-Ion Batteries with a propietary process. Our architecture accommodates silicon’s massive 280% volume expansion internally, preventing its mechanical failure. We use low-cost metallurgical Si and biomass-based carbon in a water-based process unlike costly gas-phase methods. Our"drop-in" solution for existing cell production boosts energy density by 40% with upto 80% lower CO2 footprint than competing gas-phase methods.

What problem does your technology solve, and what is the business potential?

L. A. Dold, C. Teske, P. R. Bedadur, & C. R. Bapat: Graphite has reached performance limits and carries geopolitical supply risks. We address these gaps with a silicon-based material offering superior energy density and fast charging. A profitable market entry is foreseen with niche applications like power tools and UAVs (SAM: €4.5 bn), scaling to EVs and other applications (TAM: €15 bn, CAGR 30%). With European raw materials and a patented process, we reduce strategic dependency while providing a clear cost-performance advantage over competitors.

What's the next milestone your team is working towards?

L. A. Dold, C. Teske, P. R. Bedadur, & C. R. Bapat: We are bridging the gap from lab (TRL 3) to industrial scale (TRL 6). Our next milestone is producing kilogram-scale batches and validating performance in pouch cells to release a technical data sheet targeting >500 cycles with 80 % capacity retention. With these results and five customer LOIs already in place, we plan to secure first customers and generate revenue rapidly. Further, we plan to scale toward a pilot plant (100 t/a) for the EVs and other high-performance applications.


Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read